These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 12160144

  • 1. Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.
    Sun LM, Yeh SA, Wang CJ, Huang EY, Chen HC, Hsu HC, Lee SP.
    J Neurooncol; 2002 May; 58(1):77-85. PubMed ID: 12160144
    [Abstract] [Full Text] [Related]

  • 2. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan RC, Mickle JP, Buatti JM, Mendenhall NP, Marcus RB.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):147-54. PubMed ID: 9747832
    [Abstract] [Full Text] [Related]

  • 3. Medulloblastoma in adults: treatment results and prognostic factors.
    Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A.
    Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):855-60. PubMed ID: 12377339
    [Abstract] [Full Text] [Related]

  • 4. Treatment results for 149 medulloblastoma patients from one institution.
    Khafaga Y, Kandil AE, Jamshed A, Hassounah M, DeVol E, Gray AJ.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):501-6. PubMed ID: 8655373
    [Abstract] [Full Text] [Related]

  • 5. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM.
    J Egypt Natl Canc Inst; 2008 Jun 01; 20(2):175-86. PubMed ID: 20029474
    [Abstract] [Full Text] [Related]

  • 6. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
    Fukunaga-Johnson N, Lee JH, Sandler HM, Robertson P, McNeil E, Goldwein JW.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):143-6. PubMed ID: 9747831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
    Burcu A, Nazan Ç, Özgür Ö, Serra K, Mehmet K, Serap A, Bengü D, Canan V, Haldun Ö, Savaş K, Tuncer T, Taner A, Yeşim E, Ömer K, Yavuz A.
    Childs Nerv Syst; 2018 Sep 01; 34(9):1657-1662. PubMed ID: 29868932
    [Abstract] [Full Text] [Related]

  • 11. The change in patterns of relapse in medulloblastoma.
    Tarbell NJ, Loeffler JS, Silver B, Lynch E, Lavally BL, Kupsky WJ, Scott RM, Sallan SE.
    Cancer; 1991 Oct 01; 68(7):1600-4. PubMed ID: 1893359
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H, Kayamori R, Tsuchida E, Sakai K, Shibamoto Y, Wakushima H, Ogawa Y, Kobayashi M, Obara T.
    Radiat Med; 2003 Oct 01; 21(1):37-45. PubMed ID: 12801142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.